Yayun Cui
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- RNA modifications and cancer 6
- Circular RNAs in diseases 4
- Extracellular vesicles in disease 4
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 4
- Co-authors
- Xifa Zhou (3 shared papers)Judong Luo (2 shared papers)Zhuqing Jiao (1 shared paper)Guangxia Chen (1 shared paper)Zengpeng Li (1 shared paper)Yiting Tang (1 shared paper)Yan He (1 shared paper)Qunyan Zhou (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)IEEE Access (2 papers)Frontiers in Bioengineering and Biotechnology (1 paper)Cancer Biology & Therapy (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
- Partner nations
- ChinaUnited KingdomSouth Korea
In The Last Decade
Yayun Cui
28 papers receiving 481 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 243
- Molecular Biology 316
- Oncology 73
- Immunology 32
- Pulmonary and Respiratory Medicine 40
Countries citing papers authored by Yayun Cui
This map shows the geographic impact of Yayun Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yayun Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yayun Cui more than expected).
Fields of papers citing papers by Yayun Cui
This network shows the impact of papers produced by Yayun Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yayun Cui. The network helps show where Yayun Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Yayun Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 162 | |
| 2 | Interleukin-22 secreted by cancer-associated fibroblasts regulates the proliferation and metastasis of lung cancer cells via the PI3K-Akt-mTOR signaling pathway. | 2019 | 50 |
| 3 | 2018 | 41 | |
| 4 | 2021 | 38 | |
| 5 | 2023 | 31 | |
| 6 | 2021 | 21 | |
| 7 | 2022 | 19 | |
| 8 | 2022 | 18 | |
| 9 | 2018 | 16 | |
| 10 | 2023 | 14 | |
| 11 | Neutrophil/lymphocyte ratio predicts lymph node metastasis in patients with gastric cancer. | 2023 | 10 |
| 12 | 2016 | 7 | |
| 13 | 2022 | 7 | |
| 14 | 2022 | 7 | |
| 15 | 2023 | 6 | |
| 16 | 2022 | 6 | |
| 17 | 2019 | 5 | |
| 18 | 2016 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2020 | 4 |
About Yayun Cui
Yayun Cui is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Biomedical Engineering, having authored 29 papers that have together received 483 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), RNA modifications and cancer (6 papers), Circular RNAs in diseases (4 papers), Extracellular vesicles in disease (4 papers), Cancer-related molecular mechanisms research (4 papers), interferon and immune responses (3 papers), Ultrasound Imaging and Elastography (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (243 citations), Molecular Biology (316 citations), Oncology (73 citations), Immunology (32 citations) and Pulmonary and Respiratory Medicine (40 citations). Yayun Cui has collaborated with scholars based in China, United Kingdom and South Korea. Frequent co-authors include Xifa Zhou, Judong Luo, Zhuqing Jiao, Guangxia Chen, Zengpeng Li, Yiting Tang, Yan He, Qunyan Zhou, Wenjie Wang and Shuyu Zhang. Their work appears in journals such as Frontiers in Oncology, IEEE Access, Frontiers in Bioengineering and Biotechnology, Cancer Biology & Therapy and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.